Delivery Order SPE2DB22D2108-SPE2DB25FU5FW
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,956.40 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Advair HFA 230-21 micrograms inhalers (12-gram units). This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global...
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $2,416.18 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open procurement. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Advair HFA 115-21 microgram inhalers in 12-gram quantities. The contract was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order with a ceiling value of $1,650.58. The ultimate completion date is set for July 22, 2025, with the place...
- The Defense Logistics Agency awarded a $14,025.54 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm). This is a firm fixed price delivery order with no set-aside designation, issued as a competitively awarded contract. The order is scheduled for ultimate completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 9, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm), a commonly prescribed bronchodilator medication used in respiratory care. This firm fixed-price delivery order, valued at $4,376.72, represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order valued at $14,592.35 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12-gram units) with a contract ceiling value of $6,737.52. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. This delivery...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5FWDelivery Order
The Defense Logistics Agency awarded a $10,402.76 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Advair HFA 115-21 microgram inhaler 12-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Logistics Agency's Medical Supply Chain, delivering brand-name and generic medications, vaccines, and specialized medical supplies to support military and veteran healthcare systems. The broader IDC vehicle enables the company to supply comprehensive pharmaceutical support globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue supporting federal healthcare requirements through flexible and scalable contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 7/28/25 |